The Pattern of Albumin Consumption in Teaching University Hospitals in Northeastern Iran Albumin Consumption
Iranian Journal of Pharmaceutical Sciences,
Vol. 17 No. 4 (2021),
1 October 2021
,
Page 97-106
https://doi.org/10.22037/ijps.v17.40248
Abstract
Insufficient information on accurate indications of albumin administrations and the lack of acceptable protocols emphasize the importance of performing further studies on the albumin consumption. So, the current study aimed to explore the albumin administration in the teaching hospitals to not only provide an effective pattern, but also to provide low-cost strategies for rational use of this drug. Herein, one hundred patients were given albumin during the study period, who were randomly selected from hospitals affiliated with a large public university. The collected data were analyzed using IBM SPSS Statistics (version 22). Our findings showed that 46% of the patients finally received albumin in terms of the approved guideline. In total, 777 albumin vials were used for 100 cases, for whom 414 vials (53.2%) were rationally prescribed. The albumin was frequently administrated in the ICU wards with 62% of total vials. In accordance with some previous studies, our results demonstrated that most of the albumins were prescribed inappropriately, which impose high-cost on the patients as well as on health care system. Therefore, long-term monitoring of albumin therapy implemented by trained physicians, is suggested to promote rational albumin consumption.
- albumin
- drug utilization review
- pharmacy
- protocols
- teaching hospitals
- therapy
How to Cite
References
[2] Quick JD. Ensuring access to essential medicine in the developing counteries: A framework for action. Clin. Pharmacol. Ther. (2003) 73 (4): 279-283.
[3] WHO Medicines Strategy: Framework for actions in essential drugs and medicines policy 2000-2003. World Health Organization Geneva, Switzerland, 2000. https://apps.who.int/iris/handle/10665/66503
[4] Sutharson L, Hariharan RS, and Vamsadhara C. Drug utilization study in diabetology outpatient setting of a tertiary hospital. Ind. J. Pharmacol. (2003) 35 (4): 237-240.
[5] Shalini S, Ravichandran V, Saraswathi R, Mohanty BK, and Dhanaraj SK. Drug utilization studies – an overview. Intern. J. Pharma. Sci. Nanotech. (2010) 3 (1): 803-810.
[6] Stanulovic M, Kakovijevic V, and Roncevic N. Drug utilization in paediatrics: non-medical factors affecting decision making by prescribers. Eur. S. Clin. Pharmacol. (1984) 27 (2): 237-241.
[7] Tognoni G, and Laporte J. From clinical trials to drug utilization studies. Dukes MNG (Ed) In: Drug utilization studies: Methods and uses. Copenhagen: WHO Regional office for Europe (1993) 23–41.
[8] Ramanathan R. ABC inventory classification with multiple-criteria using weighted linear optimization. Comput. Oper. Res. (2006) 33 (3): 695–700.
[9] Devnani M, Gupta AK, and Nigah R. ABC and VED analysis of the pharmacy store of a tertiary care teaching, research, and referral healthcare institute of India. J. Young. Pharm. (2010) 2 (2): 201-205.
[10] Zhou T, Lu S, Liu X, Zhang Y, and Xu F. Review of the rational use and adverse reactions to human serum albumin in the People ’ s Republic of China. Patient Prefer. Adherence. (2013) 7: 1207-1212.
[11] Tarin Remohi MJ, Sanchez Arcos A, Santos Ramos B, Bautista Paloma J, and Guerrero Aznar MD. Costs related to inappropriate use of albumin in Spain. Ann. Pharmacother. (2000) 34 (10): 1198-1205.
[12] Caraceni P, Tufoni M, and Bonavita ME. Clinical use of albumin. Blood Transfus. (2013) 11 (Suppl 4): s18–s25.
[13] Liumbruno GM, Bennardello F, Lattanzio A, Piccoli P, and Rossettias G. Recommendations for the use of albumin and immunoglobulins. Blood Transfus. (2009) 7 (3): 216-234.
[14] Vermeulen LC, Ratko TA, Erstad BL, Brecher ME, and Matuszewski KA. A paradigm for consensus the university hospital consortium guidelines for the use of albumin nonprotein colloid, and crystalloid solutions. Arch. Intern. Med. (1995) 155 (4): 373-379.
[15] Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients: Systematic review of randomised controlled trials. BMJ. (1998) 317 (7153): 235-240.
[16] Jahangard-Rafsanjani Z, Javadi MR, Torkamandi H, Alahyari S, Hojhossein Talasaz A, and Gholami K. The evaluation of albumin utilization in a teaching university hospital in Iran. Iran. J. Pharm. Res. (2011) 10 (2): 385-390.
[17] Kazemi Y, et al. Albumin utilization in a teaching hospital in Tehran: time to revise the prescribing strategies. J. Pharm. Care. (2015) 1 (4): 127-132.
[18] Farasatinasab M, et al. Albumin utilization evaluation in a major teaching hospital in Iran: Recommendations for guideline development. J. Res.Pharm. Pract. (2018) 7 (3): 157-163.
[19] Hojhossein Talasaz A, Jahangard-Rafsanjani Z, Ziaie S, and Fahimi F. Evaluation of the pattern of human albumin utilization at a university affiliated hospital. Arch. Iran. Med. (2012) 15 (2): 85–87.
[20] Shafiee E, Rezaee H, Entezari-Maleki T, and Hamishehkar H. The evaluation of albumin use in an Iranian university hospital. Pharm. Sci. (2016) 22 (3): 186–189.
[21] Foroughinia F, and Mazraie S. Investigating the use of human albumin in a non-teaching hospital in Iran. Iran. J. Pharm. Res. (2017) 16 (2): 817-822.
[22] Tanzi M, Gardner M, Megellas M, Lucio S,and Restino M. Evaluation of the appropriate use of albumin in adult and pediatric patients. Am. J. Health Syst. Pharm. (2003) 60 (13): 1330-1335.
[23] Bernardi M, Maggioli C, and Zaccherini G. Human albumin in the management of complications of liver cirrhosis. Crit. Care. (2012) 16 (2): 211.
[24] Garcia-Martinez R, Noiret L, Sen S, Mookerjee R, and Jalan R. Albumin infusion improves renal blood flow autoregulation in patients with acute decompensation of cirrhosis and acute kidney injury. Liver Int. (2015) 35 (2): 335-343.
[25] Ebrahimpour S, et al. Impact of protocol implementation on rationalization of albumin use in a tertiary care teaching hospital in Tehran, Iran. J. Res. Pharm. Pract. (2018) 7 (4): 182-187.
[26] Szczepiorkowski ZM, et al. Guidelines on the use of therapeutic apheresis in clinical practice-Evidence-based approach from the apheresis applications committee of the American Society for Apheresis. J. Clin. Apher. (2010) 25 (3): 83-177.
[27] King WS, Roland K, Selin S, Chipperfield KM, and Morrison D. Introduction of guidelines for the use of albumin and the effect on albumin prescribing practices in British Columbia. B. C. Med. J. (2012) 54 (1): 34–38.
- Abstract Viewed: 188 times
- IJPS_Volume 17_Issue 4_Pages 97-106 Downloaded: 84 times